Germany· DE-A57-0e21961e2f854919
Tobrazid
A medicinal product containing tobramycin, registered in Germany by Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Tobramycin
- Manufacturer
- Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tobramycin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBETHKISChiesi USA, Inc.
- PolandBramitobChiesi Farmaceutici S.p.A.
- United KingdomBramitob 300mg/4ml nebuliser solution 4ml ampoulesChiesi Ltd
- SpainBRAMITOB 300 mg/4 ml SOLUCION PARA INHALACION POR NEBULIZADORChiesi España S.A.U.
- SwedenBramitob 300 mg Lösning för nebulisatorChiesi Farmaceutici S.p.A.
- FinlandNebcinaEli Lilly Finland Oy Ab
- NetherlandsBramitob, verneveloplossing 300 mg/4 mlChiesi Pharmaceuticals B.V.
- CanadaSANDOZ TOBRAMYCINSANDOZ CANADA INCORPORATED
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Bramitob, Tobi
- Belgium · Obracin, Tobi
- Bulgaria · Tобрекс, Тобрамизил
- Cyprus · Bramitob, Ikobel
- Czechia · Bramitob, Tobramycin Vioser
- Denmark · Nebcina, Tobi
- Estonia · Tobramycin Via Pharma, Tobrex
- Spain · Bramitob, Tobrabact
- Finland · Tobi
- France · Nebcine, Tobi
- United Kingdom (Northern Ireland) · Bramitob, Munuza
- Greece · Bramitob, Eyetobrin
- Croatia · Bramitob, Tobrex
- Hungary · Bramitob, Brulamycin
- Ireland · Bramitob, Tobi
- Iceland · Tobi Podhaler, Vantobra
- Italy · Bramicil, Bramitob
- Liechtenstein · Tobi Podhaler, Vantobra
- Lithuania · Bramitob, Tobramycin Via Pharma
- Luxembourg · Obracin, Tobi
- Latvia · Bramitob, Tobramycin Via Pharma
- Malta · Tobi, Tobrex
- Netherlands · Bramitob, Obracin
- Norway · Bramitob, Nebcina
- Poland · Bramitob, Tobramycin Via Pharma
- Portugal · Bramitob, Tobi
- Romania · Tobi, Tobramicină Sun
- Sweden · Bramitob, Nebcina
- Slovenia · Tobrex
- Slovakia · Bramitob, Tobrex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa304c64-1171-4eb4-a969-9f8f29276c54 GET /v1/drugs/aa304c64-1171-4eb4-a969-9f8f29276c54?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Inhalation Use ,Intramuscular Use ,Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Tobramycin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about tobramycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.